State of Washington, et al. v. Philip Morris, et al. $206 billion
Hagens Berman represented 13 states in the largest recovery in litigation history.
Visa-Mastercard Antitrust Litigation $27 billion
The firm served as co-lead counsel in what was then the largest antitrust settlement in history.
Volkswagen Emissions Litigation $14.7 billion
Member of the Plaintiffs’ Steering Committee in the VW consumer litigation and part of the Settlement Negotiating team
Toyota Motor Corp. Unintended Acceleration Litigation $1.6 billion
On behalf of consumers for sudden unintended acceleration
Volkswagen Franchise Dealers Litigation $1.6 billion
Lead counsel for VW franchise dealers suit, in which a settlement has received final approval, and represents a result of nearly full damages for the class
Meracord $1.45 billion
Default judgment on behalf of consumers for useless debt-settlement conspiracy
Washington Public Power Supply System Securities Litigation $700 million
Hagens Berman’s Steve Berman represented bondholders and the bondholder trustee in a class-action lawsuit stemming from the failure of two Washington Public Power Supply System (WPPSS) nuclear projects. After years of litigation, plaintiffs were awarded a $700 million settlement agreement brought against more than 200 defendants.
E-books Antitrust $560 million
The firm took on Apple and five of the nation's largest publishing companies in an antitrust class action regarding e-book price-fixing.
LCD Antitrust Litigation $470 million
After years of representing consumers against multiple defendants in multi-district litigation, the total settlements in the litigation exceeded $470 million.
McKesson Drug Litigation $444 million
Hagens Berman was lead counsel in these racketeering cases against McKesson for drug pricing fraud that settled on the eve of trials.
DaVita Dialysis Wrongful Death Cases $383.5 million
Hagens Berman's expert trial attorneys recently won a monumental $383.5 million jury verdict on behalf of three families of dialysis patients who died after receiving treatment from DaVita.
DRAM Antitrust Litigation $345 million
The firm was co-lead counsel, and the case settled in favor of purchasers of dynamic random access memory chips (DRAM).
Average Wholesale Price Drug Litigation $338 million
Hagens Berman was co-lead counsel in this ground-breaking drug pricing case against the world’s largest pharmaceutical companies, resulting in a victory at trial.
Neurontin Pfizer Litigation $325 million
The firm brought suit against Pfizer and its subsidiary, Parke-Davis, accusing the companies of a fraudulent scheme to market and sell the drug Neurontin for a variety of "off-label" uses for which it is not approved or medically efficacious.
Stericycle, Steri-Safe Litigation $255 million
Hagens Berman represented small businesses including veterinary clinics, medical and dental clinics, and medical labs in a class-action lawsuit alleging Stericycle's billing practices and accounting software violated consumers laws and constituted breach of contract.
Hyundai & Kia Fuel Economy Litigation $255 million
Hagens Berman represented consumers in this class-action lawsuit, in which the court granted preliminary approval to the settlement potentially worth over $255 million.
Enron ERISA Litigation $250 million
Hagens Berman was co-lead counsel in this ERISA litigation, the largest ERISA settlement in history.
Charles Schwab Securities Litigation $235 million
The firm was lead counsel in this action alleging fraud in the management of the Schwab YieldPlus mutual fund; a class settlement was approved by the court.
NCAA Scholarship Cap Antitrust Litigation $208 million
The firm was lead counsel in this action claiming that the NCAA agreed in violation of national antitrust laws to unlawfully cap the value of athletic scholarships.
New England Compounding Pharmacy Meningitis Outbreak Litigation $200 million
Hagens Berman attorneys Thomas M. Sobol and Kristen A. Johnson serve as court-appointed lead counsel for the Plaintiffs’ Steering Committee on behalf of plaintiff-victims of the 2012 fungal meningitis outbreak.
Lupron Consumer Litigation $150 million
Hagens Berman secured a settlement on behalf of patients using Lupron for prostate cancer.
Flonase Antitrust Litigation $150 million
Hagens Berman served as court-appointed co-lead class counsel of a class of direct purchasers alleging that GlaxoSmithKline intentionally submitted a sham citizen petitions to the U.S. Food and Drug Administration, and actually delayed the approval of generic versions of Flonase.
Expedia Hotel Taxes and Fees Litigation $123.4 million
Hagens Berman obtained summary judgment in this class action to recover deceptive service fees and settled the case.
Oppenheimer Core Bond and Champion Income Funds Litigation $100 million
Hagens Berman obtained these combined settlements in two case alleging that various Oppenheimer entities and certain individual defendants made materially false or misleading statements and omissions to the investing public regarding the investment profile and objectives of the two funds.
Tremont Group Holdings Litigation $100 million
The court appointed Hagens Berman co-lead counsel in this class-action lawsuit on behalf of investors and groups that invested capital with Tremont Group Holdings.
Prograf Antitrust Litigation $98 million
Hagens Berman served as court-appointed co-lead class counsel representing a class of direct purchasers of Prograf.
Boeing Securities Litigation $92.5 million
Boeing and Hagens Berman agreed to a proposed settlement to the shareholder suit filed in November 1997 by Hagens Berman. The settlement, second largest awarded in the Northwest, affected tens of thousands of shareholders who purchased or otherwise acquired Boeing common stock.